william meisel

/Tag:william meisel

FDA Rules To Reclassify POP Vaginal Mesh as High Risk!

Uphold, Boston Scientific, still on the market January 4, 2016 ~ An expert panel convened by the U.S. Food and Drug Administration (FDA) decided in September 2011 that mesh used to treat pelvic organ prolapse (POP) should be reclassified as high risk from its moderate risk (Class II) Read more

By | 2018-07-10T14:45:41+00:00 January 4th, 2016|News|42 Comments